Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database

ObjectiveTo explore the risk factors for survival and prognosis of patients with metastatic endometrial cancer and to build and verify a reliable prediction model.MethodsWe retrospectively analyzed patients diagnosed with metastatic endometrial cancer in the US Surveillance, Epidemiology, and End Re...

Full description

Bibliographic Details
Main Authors: Meng Zhang, Ruiping Li, Shan Zhang, Xin Xu, Lixin Liao, Yan Yang, Yuzhen Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2022.1001791/full
_version_ 1797959973201772544
author Meng Zhang
Ruiping Li
Shan Zhang
Xin Xu
Lixin Liao
Yan Yang
Yuzhen Guo
author_facet Meng Zhang
Ruiping Li
Shan Zhang
Xin Xu
Lixin Liao
Yan Yang
Yuzhen Guo
author_sort Meng Zhang
collection DOAJ
description ObjectiveTo explore the risk factors for survival and prognosis of patients with metastatic endometrial cancer and to build and verify a reliable prediction model.MethodsWe retrospectively analyzed patients diagnosed with metastatic endometrial cancer in the US Surveillance, Epidemiology, and End Results (SEER) database between January 2010 and December 2015. Univariate and multivariate Cox regression analyses were used to assess clinical variables impact on survival and to construct nomograms. The results of the consistency index (C-index), subject operating characteristic (ROC) curve, and calibration curve were used to evaluate the predictive ability of the nomogram.ResultsThis study included 3,878 patients with metastatic endometrial cancer. In the univariate analysis, variables associated with overall survival (OS) and cancer-specific survival (CSS) included age, race, marital status, pathological type, pathological grade, T-stage, N-stage, surgery, radiotherapy, chemotherapy, bone metastasis, brain metastasis, liver metastasis, and lung metastasis. In the multivariate analysis, age, race, pathological type, pathological grade, T-stage, N-stage, surgery, radiotherapy, chemotherapy, brain metastasis, liver metastasis, and lung metastasis were independent risk factors for OS and CSS (all P < 0.05). Combined with the results of the multiple factors, the 1-, 3-, 5-, and 8-year nomograms were constructed. For OS and CSS, T-stage had the greatest impact on the adverse prognosis of patients with metastatic endometrial cancer. The C-indexes of the OS and CSS nomograms in the training cohort were 0.749 (95% CI, 0.739–0.760) and 0.746 (95% CI, 0.736–0.756), respectively. The C-indices of OS and CSS in the validation cohort were 0.730 (95% CI, 0.714–0.746) and 0.728 (95% CI, 0.712–0.744), respectively. The ROC curve revealed our model's good prediction accuracy and clinical practicability. The calibration curve also confirmed the consistency between the model and actual existence. The Kaplan-Meier curves revealed statistically significant differences between the risk subgroups (P < 0.05).ConclusionOur SEER-based nomograms for predicting survival in patients with metastatic endometrial cancer were helpful for the clinical evaluation of patient prognosis.
first_indexed 2024-04-11T00:39:17Z
format Article
id doaj.art-89ff9da41631418a9f8adb3e4ad34c01
institution Directory Open Access Journal
issn 2296-875X
language English
last_indexed 2024-04-11T00:39:17Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj.art-89ff9da41631418a9f8adb3e4ad34c012023-01-06T09:38:09ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2023-01-01910.3389/fsurg.2022.10017911001791Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results databaseMeng ZhangRuiping LiShan ZhangXin XuLixin LiaoYan YangYuzhen GuoObjectiveTo explore the risk factors for survival and prognosis of patients with metastatic endometrial cancer and to build and verify a reliable prediction model.MethodsWe retrospectively analyzed patients diagnosed with metastatic endometrial cancer in the US Surveillance, Epidemiology, and End Results (SEER) database between January 2010 and December 2015. Univariate and multivariate Cox regression analyses were used to assess clinical variables impact on survival and to construct nomograms. The results of the consistency index (C-index), subject operating characteristic (ROC) curve, and calibration curve were used to evaluate the predictive ability of the nomogram.ResultsThis study included 3,878 patients with metastatic endometrial cancer. In the univariate analysis, variables associated with overall survival (OS) and cancer-specific survival (CSS) included age, race, marital status, pathological type, pathological grade, T-stage, N-stage, surgery, radiotherapy, chemotherapy, bone metastasis, brain metastasis, liver metastasis, and lung metastasis. In the multivariate analysis, age, race, pathological type, pathological grade, T-stage, N-stage, surgery, radiotherapy, chemotherapy, brain metastasis, liver metastasis, and lung metastasis were independent risk factors for OS and CSS (all P < 0.05). Combined with the results of the multiple factors, the 1-, 3-, 5-, and 8-year nomograms were constructed. For OS and CSS, T-stage had the greatest impact on the adverse prognosis of patients with metastatic endometrial cancer. The C-indexes of the OS and CSS nomograms in the training cohort were 0.749 (95% CI, 0.739–0.760) and 0.746 (95% CI, 0.736–0.756), respectively. The C-indices of OS and CSS in the validation cohort were 0.730 (95% CI, 0.714–0.746) and 0.728 (95% CI, 0.712–0.744), respectively. The ROC curve revealed our model's good prediction accuracy and clinical practicability. The calibration curve also confirmed the consistency between the model and actual existence. The Kaplan-Meier curves revealed statistically significant differences between the risk subgroups (P < 0.05).ConclusionOur SEER-based nomograms for predicting survival in patients with metastatic endometrial cancer were helpful for the clinical evaluation of patient prognosis.https://www.frontiersin.org/articles/10.3389/fsurg.2022.1001791/fullendometrial cancermetastasisSEER databasenomogrampredictive model fund program: natural science foundation of gansu province(17JR5RA242)
spellingShingle Meng Zhang
Ruiping Li
Shan Zhang
Xin Xu
Lixin Liao
Yan Yang
Yuzhen Guo
Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database
Frontiers in Surgery
endometrial cancer
metastasis
SEER database
nomogram
predictive model fund program: natural science foundation of gansu province(17JR5RA242)
title Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database
title_full Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database
title_fullStr Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database
title_full_unstemmed Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database
title_short Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database
title_sort analysis of prognostic factors of metastatic endometrial cancer based on surveillance epidemiology and end results database
topic endometrial cancer
metastasis
SEER database
nomogram
predictive model fund program: natural science foundation of gansu province(17JR5RA242)
url https://www.frontiersin.org/articles/10.3389/fsurg.2022.1001791/full
work_keys_str_mv AT mengzhang analysisofprognosticfactorsofmetastaticendometrialcancerbasedonsurveillanceepidemiologyandendresultsdatabase
AT ruipingli analysisofprognosticfactorsofmetastaticendometrialcancerbasedonsurveillanceepidemiologyandendresultsdatabase
AT shanzhang analysisofprognosticfactorsofmetastaticendometrialcancerbasedonsurveillanceepidemiologyandendresultsdatabase
AT xinxu analysisofprognosticfactorsofmetastaticendometrialcancerbasedonsurveillanceepidemiologyandendresultsdatabase
AT lixinliao analysisofprognosticfactorsofmetastaticendometrialcancerbasedonsurveillanceepidemiologyandendresultsdatabase
AT yanyang analysisofprognosticfactorsofmetastaticendometrialcancerbasedonsurveillanceepidemiologyandendresultsdatabase
AT yuzhenguo analysisofprognosticfactorsofmetastaticendometrialcancerbasedonsurveillanceepidemiologyandendresultsdatabase